Gern, James E.
- University of Wisconsin-Madison · Pediatrics (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #463
- Rising Star
- Sustained Excellence
- Top 5% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pediatrics
NIH Funding · FY2023
Linked Award Amount
$6.8M
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#463
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Gern, James E. as a PI. Multi-PI records show the full award amount for context.
- 5UM1AI160040-03UM1Contact PIChildhood Asthma in Urban Settings Clinical Research Network - Leadership CenterUniversity of Wisconsin-Madison · Pediatrics (NIH department code)$6.8Maward amount
Award organization
Organizations that administered FY2023 awards listing Gern, James E. as a PI.
FY2023 award administered by University of Wisconsin-Madison (WI).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardUniversity of Wisconsin-Madison
- 2004$500K Cumulative Funding
- 2005$1M Cumulative Funding
- 2005$2M Cumulative Funding
- 2005Entered Top 50% NationallyRanked #2012
- 2005Entered Top 25% NationallyRanked #2012
- 2019$5M Cumulative Funding
- 2019$10M Cumulative Funding
- 2019Entered Top 10% NationallyRanked #161
- 2019Entered Top 5% NationallyRanked #161
- 2019Entered Top 1% NationallyRanked #161
- 2022$25M Cumulative Funding